This proposes a plausible method by which melanoma following a mitogenic mutation, such as the NRAS or BRAF mutations, are repressed by the p16/Rb pathway, validating the hypothesis that senescence is a very effective defense against cancer [68]. This evidence concerns the gene RB1 and cancer.